Issues on the current information system

Slides:



Advertisements
Similar presentations
Improving diagnosis TB laboratory strengthening.
Advertisements

Monitoring PPM contributions – from operational research to regular reporting Knut Lönnroth Stop TB Department 5 th PPM Subgroup Meeting Cairo, 4 June.
TB and poverty agenda in WPR WHO/WPRO Stop TB. World Health Organization Percentage of population living below US$1 a day.
End TB strategy target setting
Monitoring and Evaluation Frameworks Kyiv, Ukraine May 23, 2006 MEASURE Evaluation.
An Introduction to Monitoring and Evaluation for National TB Programs.
Monitoring and Evaluation: A Review of Terms. Goals To provide better treatment for people with tuberculosis in Country X To achieve a treatment success.
Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs Using the Compendium to Plan for Monitoring and Evaluation of NTPs.
Introduction to Monitoring and Evaluation for National TB Programs 20 September 2005.
Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs.
Monitoring and Evaluation Frameworks   What is an M&E Framework?   Why do we use M&E Frameworks?   How do we develop M&E Frameworks? MEASURE Evaluation.
Technical Advisory Group meeting, WHO/WPRO
Revised National Tuberculosis Control Programme (RNTCP)
1 Global and Regional Tuberculosis (TB) update ACSM workshop, Amman, Jordan April 13-17, 2008 Dr. Sevil Huseynova.
1 TB/HIV Project in the Philippines Yumiko Yanase.
Progress and Plans for PPM in the Western Pacific Region Fifth PPM DOTS Subgroup Meeting Cairo, Egypt.
Monitoring and Evaluation Module 12 – March 2010.
U pdates on the development of the NTP National Strategic Plan GC National TB Conference Pokhara, July 14-15, 2014 Giampaolo Mezzabotta Medical.
African Business Leaders on Health: GBC Conference on TB, HIV-TB Co-infection & Global Fund Partnership Johannesburg, October 11, 2010 The state of Global.
Missed opportunities to diagnose TB and HIV Co-infection in HIV workplace program Dr Fred Mugyenyi Asiimwe Medical Director, ALAFA.
Japan Dr. Ismail M. Aboshama Zidan Surveillance Coordinator of NTP-Egypt Action Plan to Strengthen Laboratory Diagnostic.
Indicators for ACSM.
NATIONAL TB 2012 INDICATOR ANALYSIS REPORT Presented by: Sandile Ginindza Lugogo Sun Hotel 05 th -7 th June 2013 Ministry of Health NTCP.
TB/HIV COLLABORATION IN GHANA Dr. Nii Nortey Hanson – Nortey National TB Control Programme Accra.
Health Organization The Challenges Facing Tuberculosis Control Blantyre Hospital, Malawi: TB Division, 3 patients per bed.
From Mekong to Bali: The scale up of TB/HIV collaborative activities in Asia- Pacific, August 8-9, 2009 Denpasar, Bali, Indonesia "TB/HIV Monitoring and.
HIV TESTING AND EXPANSION OF ART FOR TB PATIENTS, BOTTLE NECKS CHALLENGES AND ENABLERS FOR SCALE UP IN KENYA DR. JOSEPH SITIENEI, OGW NTP MANAGER - KENYA.
Dr Ral Antic Chair Scientific Committee IUATLD-APR Australia Pre-Conference Workshop 1 National TB Control Program Summary & Remarks.
Outline of Current Situation Survey on HIV/AIDS (Proposal) Ms. Keiko Dozono Director for AIDS and Emerging Infectious Disease Control Health and Safety.
Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs.
Challenges and Constraints for TB Control in Kenya Dr. James Nyikal Director of Medical Services, Kenya.
World Tuberculosis Day 2016 Monitoring the implementation of the Framework Action Plan to Fight Tuberculosis in the European Union – Situation in 2014.
Did we reach the 2005 targets? Will we achieve the Millennium Development Goals?
TB/ HIV CONTROL AND MANAGEMENT IN SOUTH AFRICA
Monitoring and Evaluation: A Review of Terms
Monitoring and Evaluation Frameworks
Central American Certificate Course: HIV Monitoring and Evaluation for HIV/AIDS Policy and Program Management BZ Unit 2 – Post test CR ES GT NI PA January.
World Tuberculosis Day 2014
Philippe Glaziou Geneva, 12 October 2009
Progress in Implementing collaborative TB/HIV activities
TB Control in PHC network and Partners Coordination in Cambodia
The burden of TB in the Western Pacific
Monitoring the implementation of the TB Action Plan for the WHO European Region, 2016–2020 EU/EEA situation in 2016 ECDC Tuberculosis Programme European.
Antiretroviral therapy coverage in sub-Saharan Africa,
Key issues in DOTS implementation
World Tuberculosis Day 2016
World Tuberculosis Day 2014
Dr. Joseph Bana-Koiri Dr. Gilbert Hiawalyer Papua New Guinea
Objectives of Session Provide an overview of the development of Compendium Explain the organization of the Compendium and how indicators are used Provide.
Health system assessments
SURVEILLANCE AND EPIDEMIOLOGY OF TUBERCULOSIS IN FIJI
National Tuberculosis Control Program Department of Health Philippines Dr. Vivian S. Lofranco Medical Specialist IV.
Cheng shiming National TB Center in China May,3, 2004
National Tuberculosis Control Program in Vietnam
monitoring & evaluation THD Unit, Stop TB department WHO Geneva
Objectives of the workshop
PROGRESS IN GLOBAL TB CONTROL
Country Presentation CAMBODIA
THE GLOBAL EPIDEMIOLOGY OF TUBERCULOSIS WORLD HEALTH ORGANIZATION
TB SUREVEILLANCE MEETING: OBJECTIVES
Collaborative TB/HIV activities in European Region
TB notification in Hong Kong
Country presentation Dr.Vija Riekstina National TB registry
The STOP TB Strategy – 2009 VISION: A TB-free world
Intensified Case-Finding 1
Background & rational DEWG meeting 2009
Current status – (1) Achievements Building strong political commitment
Monitoring and Evaluation: A Review of Terms
Global DOTS Expansion: will we reach the Targets?
5th edition NTP MANUAL OF PROCEDURES Chapter 1: Introduction
Presentation transcript:

Issues on the current information system Stop TB, WHO/WPRO

Objectives of the WHO TB information system Understanding the burden of TB Measure progress in TB control and implementing the DOTS strategy Increased political awareness Targeting of resources Monitoring and Evaluation

Data flow

Data management  NTP Country Office WPRO WHO/HQ Data collection Data verification Data entry Calculation (notification) Calculation (estimates) Reporting

Western Pacific Region targets 2005 100% DOTS coverage 85% cure rate 70% case detection rate 2010 Reduce morbidity by half Reduce mortality by half

Measuring progress (2005 targets) 100% DOTS 85% cure 70% case detection % population covered by DOTS units Cohort analysis of treatment outcomes Notified / Estimated new cases

Monitor strategies to address low CDR in the WPR Improving the quality of laboratory services: % TB labs with a standardized QA programme TB and poverty strategy Indicators of social exclusion? (income, ethnicity, locality and employment status) Expansion of Public-Private Mix strategy % cases detected in the private sector HIV/TB activities HIV prevalence in TB cases % TB cases offered VCT services % newly detected TB cases screened for TB

Measuring progress (2010 targets) Reduce prevalence by half Reduce mortality by half Monitor prevalence: Prevalence surveys Other sources of data: indirect estimates Monitor mortality: Vital Registration system Surveys Other sources of data

Constraints Simplicity Consistency with time: need to assess trends Transmission of forms Clear definitions Limited number of items Consistency with time: need to assess trends Information system useful to NTPs and to partners New strategies  new indicators